Paulson & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-349,500
Closed -$1.94M 58
2017
Q2
$1.94M Buy
+349,500
New +$1.94M 0.03% 86
2017
Q1
Sell
-52,600
Closed -$333K 93
2016
Q4
$333K Sell
52,600
-310,500
-86% -$1.97M ﹤0.01% 87
2016
Q3
$1.6M Buy
363,100
+100,000
+38% +$441K 0.02% 83
2016
Q2
$747K Hold
263,100
0.01% 76
2016
Q1
$745K Buy
+263,100
New +$745K 0.01% 83